University of Oxford Department of Oncology
@oncology.ox.ac.uk
Reposted by University of Oxford Department of Oncology
The Oxford Centre for Cancer Early Detection and Prevention (OxCODE) Funding Scheme is open!
🔎Pump-priming cancer early detection and prevention research
🧪Open to @ox.ac.uk researchers
💷£20K 1-year awards
📆Deadline: Fri 27 Feb
More on the OxCODE website 👇
www.oxcode.ox.ac.uk/about/oxcode....
🔎Pump-priming cancer early detection and prevention research
🧪Open to @ox.ac.uk researchers
💷£20K 1-year awards
📆Deadline: Fri 27 Feb
More on the OxCODE website 👇
www.oxcode.ox.ac.uk/about/oxcode....
January 14, 2026 at 10:41 AM
The Oxford Centre for Cancer Early Detection and Prevention (OxCODE) Funding Scheme is open!
🔎Pump-priming cancer early detection and prevention research
🧪Open to @ox.ac.uk researchers
💷£20K 1-year awards
📆Deadline: Fri 27 Feb
More on the OxCODE website 👇
www.oxcode.ox.ac.uk/about/oxcode....
🔎Pump-priming cancer early detection and prevention research
🧪Open to @ox.ac.uk researchers
💷£20K 1-year awards
📆Deadline: Fri 27 Feb
More on the OxCODE website 👇
www.oxcode.ox.ac.uk/about/oxcode....
2025 in numbers.
A year of research, teaching, and collaboration.
A year of research, teaching, and collaboration.
January 14, 2026 at 1:21 PM
2025 in numbers.
A year of research, teaching, and collaboration.
A year of research, teaching, and collaboration.
TrustedMDT is a multi-agent AI system designed to support cancer treatment planning.
The tool is made up of three agents, integrated into Microsoft teams, that work in concert to summarise clinical records, determine disease stage & draft evidence-based treatment recommendations.
@medsci.ox.ac.uk
The tool is made up of three agents, integrated into Microsoft teams, that work in concert to summarise clinical records, determine disease stage & draft evidence-based treatment recommendations.
@medsci.ox.ac.uk
January 7, 2026 at 11:36 AM
TrustedMDT is a multi-agent AI system designed to support cancer treatment planning.
The tool is made up of three agents, integrated into Microsoft teams, that work in concert to summarise clinical records, determine disease stage & draft evidence-based treatment recommendations.
@medsci.ox.ac.uk
The tool is made up of three agents, integrated into Microsoft teams, that work in concert to summarise clinical records, determine disease stage & draft evidence-based treatment recommendations.
@medsci.ox.ac.uk
Reposted by University of Oxford Department of Oncology
Parkes lab pre-print alert! ‘TMEM33 deletion potentiates anti-tumor CD8⁺ T cell immunity.’ Led by mtjackson101.bsky.social. Full bluetutorial follows! 1/10 www.biorxiv.org/content/10.6...
January 5, 2026 at 3:30 PM
Parkes lab pre-print alert! ‘TMEM33 deletion potentiates anti-tumor CD8⁺ T cell immunity.’ Led by mtjackson101.bsky.social. Full bluetutorial follows! 1/10 www.biorxiv.org/content/10.6...
New Vacancy: Postdoctoral Researcher in Bioinformatics & Human Tissue Modelling
We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers.
www.oncology.ox.ac.uk/about-us/wor...
We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers.
www.oncology.ox.ac.uk/about-us/wor...
December 19, 2025 at 1:45 PM
New Vacancy: Postdoctoral Researcher in Bioinformatics & Human Tissue Modelling
We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers.
www.oncology.ox.ac.uk/about-us/wor...
We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers.
www.oncology.ox.ac.uk/about-us/wor...
Reposted by University of Oxford Department of Oncology
NEW: Oxford researchers have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.
Find out more ⬇️
Find out more ⬇️
Oxford-built multi-agent assistant for cancer care to be piloted in
Researchers at the University of Oxford have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.
www.ox.ac.uk
December 17, 2025 at 11:54 AM
NEW: Oxford researchers have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.
Find out more ⬇️
Find out more ⬇️
Congratulations to Kendra Perez-Smith, Translational Support Unit Manager, who has received an Outstanding Contribution to Sustainability Award for her innovation & leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.
Kendra Perez-Smith receives Outstanding Contribution to Sustainability Award
The Department of Oncology is proud to share that Kendra Perez-Smith, Translational Support Unit (TSU) Manager, has received an Outstanding Contribution to Sustainability Award in recognition of her i...
www.oncology.ox.ac.uk
December 17, 2025 at 12:53 PM
Congratulations to Kendra Perez-Smith, Translational Support Unit Manager, who has received an Outstanding Contribution to Sustainability Award for her innovation & leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.
Researchers at @oncology.ox.ac.uk have developed TrustedMDT, a multi-agent AI system designed to support cancer treatment planning.
TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations.
Read more ⬇️
TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations.
Read more ⬇️
Oxford-Built Multi-Agent assistant for Cancer Care to be piloted in collaboration with Microsoft
Researchers at the Department of Oncology have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings...
www.oncology.ox.ac.uk
December 16, 2025 at 11:47 AM
Researchers at @oncology.ox.ac.uk have developed TrustedMDT, a multi-agent AI system designed to support cancer treatment planning.
TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations.
Read more ⬇️
TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations.
Read more ⬇️
Congratulations to Keaton Jones who has received a @wellcometrust.bsky.social Early Career Award 🔬
The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.
The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.
New Study to Investigate How Immunometabolism Shapes Treatment Responses in Pancreatic Cancer
www.oncology.ox.ac.uk
December 8, 2025 at 1:11 PM
Congratulations to Keaton Jones who has received a @wellcometrust.bsky.social Early Career Award 🔬
The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.
The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.
Reposted by University of Oxford Department of Oncology
Congratulations to the team at Brighton and Sussex for recruiting 61 participants to SCOOT. @uhsussex.bsky.social @chestconsultant.bsky.social @oncology.ox.ac.uk
#lungcancer #personalisedtherapy and #earlydiagnosis
#lungcancer #personalisedtherapy and #earlydiagnosis
December 1, 2025 at 2:04 PM
Congratulations to the team at Brighton and Sussex for recruiting 61 participants to SCOOT. @uhsussex.bsky.social @chestconsultant.bsky.social @oncology.ox.ac.uk
#lungcancer #personalisedtherapy and #earlydiagnosis
#lungcancer #personalisedtherapy and #earlydiagnosis
Reposted by University of Oxford Department of Oncology
In case you missed it!
Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford!
Read more ⬇️
@sarahblagden.bsky.social @medsci.ox.ac.uk
www.cancer.ox.ac.uk/news/profess...
Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford!
Read more ⬇️
@sarahblagden.bsky.social @medsci.ox.ac.uk
www.cancer.ox.ac.uk/news/profess...
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of...
www.cancer.ox.ac.uk
November 25, 2025 at 10:39 AM
In case you missed it!
Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford!
Read more ⬇️
@sarahblagden.bsky.social @medsci.ox.ac.uk
www.cancer.ox.ac.uk/news/profess...
Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford!
Read more ⬇️
@sarahblagden.bsky.social @medsci.ox.ac.uk
www.cancer.ox.ac.uk/news/profess...
Reposted by University of Oxford Department of Oncology
Oxford Professor Sarah Blagden, @oncology.ox.ac.uk appears in the first episode of Cancer Detectives: Finding the Cures on @Channel4 tonight!
📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4.
Brought to you by @CR_UK.
#CancerDetectives #CancerPrevention
www.channel4.com/programmes/c...
📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4.
Brought to you by @CR_UK.
#CancerDetectives #CancerPrevention
www.channel4.com/programmes/c...
Cancer Detectives: Finding the Cures
Three trailblazing scientists take on cancer, changing peoples’ lives, right now
www.channel4.com
November 20, 2025 at 11:47 AM
Oxford Professor Sarah Blagden, @oncology.ox.ac.uk appears in the first episode of Cancer Detectives: Finding the Cures on @Channel4 tonight!
📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4.
Brought to you by @CR_UK.
#CancerDetectives #CancerPrevention
www.channel4.com/programmes/c...
📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4.
Brought to you by @CR_UK.
#CancerDetectives #CancerPrevention
www.channel4.com/programmes/c...
Reposted by University of Oxford Department of Oncology
We’re thrilled to partner with Channel 4 on ‘Cancer Detectives: Finding the Cures’ - a new series which is shining a light on three trailblazing scientists taking on cancer, and explores how their work is changing patients’ lives right now. 👇 1/2
November 20, 2025 at 9:37 AM
We’re thrilled to partner with Channel 4 on ‘Cancer Detectives: Finding the Cures’ - a new series which is shining a light on three trailblazing scientists taking on cancer, and explores how their work is changing patients’ lives right now. 👇 1/2
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial.
@medsci.ox.ac.uk @oxfordcancer.bsky.social
People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial.
@medsci.ox.ac.uk @oxfordcancer.bsky.social
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine ca...
www.oncology.ox.ac.uk
November 17, 2025 at 2:58 PM
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial.
@medsci.ox.ac.uk @oxfordcancer.bsky.social
People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial.
@medsci.ox.ac.uk @oxfordcancer.bsky.social
Reposted by University of Oxford Department of Oncology
Next up in the Meet The MILI Team series, is Dr Schaida Schirwani.
Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton.
#LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk
@oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton.
#LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk
@oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
November 13, 2025 at 1:23 PM
Next up in the Meet The MILI Team series, is Dr Schaida Schirwani.
Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton.
#LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk
@oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton.
#LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk
@oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
Reposted by University of Oxford Department of Oncology
What if we could stop #Cancer before it even starts?
Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast.
🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou...
@sarahblagden.bsky.social @medsci.ox.ac.uk
Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast.
🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou...
@sarahblagden.bsky.social @medsci.ox.ac.uk
November 12, 2025 at 1:02 PM
What if we could stop #Cancer before it even starts?
Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast.
🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou...
@sarahblagden.bsky.social @medsci.ox.ac.uk
Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast.
🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou...
@sarahblagden.bsky.social @medsci.ox.ac.uk
INTREPID is one of five interdisciplinary teams launched
as part of a new UK initiative to transform disease research through the development of advanced human tissue models.
The team will evaluate & optimise the use of patient-derived explants as tumour models.
Learn more:
as part of a new UK initiative to transform disease research through the development of advanced human tissue models.
The team will evaluate & optimise the use of patient-derived explants as tumour models.
Learn more:
Oxford joins £15.9m national initiative to transform cancer research
Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise
www.ox.ac.uk
November 12, 2025 at 10:00 AM
INTREPID is one of five interdisciplinary teams launched
as part of a new UK initiative to transform disease research through the development of advanced human tissue models.
The team will evaluate & optimise the use of patient-derived explants as tumour models.
Learn more:
as part of a new UK initiative to transform disease research through the development of advanced human tissue models.
The team will evaluate & optimise the use of patient-derived explants as tumour models.
Learn more:
Reposted by University of Oxford Department of Oncology
Funded PhD available working with us on tumour hypoxia and radiosensitivity at @oncology.ox.ac.uk @ox.ac.uk Closing date 2nd Dec www.oncology.ox.ac.uk/study-with-u...
Oxford Wolfson Marriott Graduate Scholarship: Investigating changes in RNA-binding proteins in hypoxia as a means of increasing radiosensitivity
www.oncology.ox.ac.uk
November 5, 2025 at 4:19 PM
Funded PhD available working with us on tumour hypoxia and radiosensitivity at @oncology.ox.ac.uk @ox.ac.uk Closing date 2nd Dec www.oncology.ox.ac.uk/study-with-u...
Sruthi Shakthivel is a technician in the Translational Support Unit (TSU), a dedicated unit within @octooxford.bsky.social that focuses on the operational & scientific side of biological sample management in clinical trials.
Sruthi shares insights on the mission of the TSU & what her role involves:
Sruthi shares insights on the mission of the TSU & what her role involves:
Staff Spotlight: Working as a Technician in the Translational Support Unit
Sruthi Shakthivel works as a technician in the Translational Support Unit (TSU), a dedicated unit within the Oncology Clinical Trials Office (OCTO) that focuses on the operational and scientific side…
buff.ly
November 3, 2025 at 4:34 PM
Sruthi Shakthivel is a technician in the Translational Support Unit (TSU), a dedicated unit within @octooxford.bsky.social that focuses on the operational & scientific side of biological sample management in clinical trials.
Sruthi shares insights on the mission of the TSU & what her role involves:
Sruthi shares insights on the mission of the TSU & what her role involves:
Reposted by University of Oxford Department of Oncology
#WIMMReads
Fairfax Group ( @bpfairfax.bsky.social ) map how genetic variation shapes monocyte gene expression and splicing across immune contexts 🧪
Read more 👇
doi.org/10.1038/s414...
#Genomics #Immunology #Transcriptomics
Fairfax Group ( @bpfairfax.bsky.social ) map how genetic variation shapes monocyte gene expression and splicing across immune contexts 🧪
Read more 👇
doi.org/10.1038/s414...
#Genomics #Immunology #Transcriptomics
Genetic determinants of monocyte splicing are enriched for disease susceptibility loci - Nature Communications
Our understanding of variation in monocyte context-specific splicing and transcript usage is limited. Here, the authors find genetic variants that affect gene splicing in monocytes in specific co...
doi.org
October 30, 2025 at 12:04 PM
#WIMMReads
Fairfax Group ( @bpfairfax.bsky.social ) map how genetic variation shapes monocyte gene expression and splicing across immune contexts 🧪
Read more 👇
doi.org/10.1038/s414...
#Genomics #Immunology #Transcriptomics
Fairfax Group ( @bpfairfax.bsky.social ) map how genetic variation shapes monocyte gene expression and splicing across immune contexts 🧪
Read more 👇
doi.org/10.1038/s414...
#Genomics #Immunology #Transcriptomics
Members of the Department of Oncology were at ESMO 2025 in Berlin last week to present their research, chair sessions, and network with collaborators.
Read about some of the highlights from our department’s contributions to the congress:
www.oncology.ox.ac.uk/news/esmo-2025
Read about some of the highlights from our department’s contributions to the congress:
www.oncology.ox.ac.uk/news/esmo-2025
Oxford Oncology at ESMO 2025
Members of the Department of Oncology attended ESMO earlier this month to present their research, chair sessions, and network with collaborators from across Europe and beyond. Read the highlights from...
www.oncology.ox.ac.uk
October 29, 2025 at 12:52 PM
Members of the Department of Oncology were at ESMO 2025 in Berlin last week to present their research, chair sessions, and network with collaborators.
Read about some of the highlights from our department’s contributions to the congress:
www.oncology.ox.ac.uk/news/esmo-2025
Read about some of the highlights from our department’s contributions to the congress:
www.oncology.ox.ac.uk/news/esmo-2025
Reposted by University of Oxford Department of Oncology
Explore internships and graduate roles with organisations from a variety of technical area the Science, Engineering & Technology Fair @ox.ac.uk
📅 Saturday 25 October 2025
⌚ Exhibitors from 10:30-13:30; Pre-fair talks from 09:45
📍 Examination Schools, OX1 4BG
👉 www.careers.ox.ac.uk/set
📅 Saturday 25 October 2025
⌚ Exhibitors from 10:30-13:30; Pre-fair talks from 09:45
📍 Examination Schools, OX1 4BG
👉 www.careers.ox.ac.uk/set
October 22, 2025 at 8:11 AM
Explore internships and graduate roles with organisations from a variety of technical area the Science, Engineering & Technology Fair @ox.ac.uk
📅 Saturday 25 October 2025
⌚ Exhibitors from 10:30-13:30; Pre-fair talks from 09:45
📍 Examination Schools, OX1 4BG
👉 www.careers.ox.ac.uk/set
📅 Saturday 25 October 2025
⌚ Exhibitors from 10:30-13:30; Pre-fair talks from 09:45
📍 Examination Schools, OX1 4BG
👉 www.careers.ox.ac.uk/set
We would like to congratulate our MSc course prize winners, who each achieved the highest mark in their cohort for 2024-25.
Many congratulations to Maria, Jack, Carla & Yael on this outstanding achievement. We are confident they have impressive futures ahead as leaders in the field of oncology.
Many congratulations to Maria, Jack, Carla & Yael on this outstanding achievement. We are confident they have impressive futures ahead as leaders in the field of oncology.
Celebrating Excellence: MSc Prize Winners 2024–25
The 2024-25 academic year has drawn to a close and we are saying goodbye to an exceptional cohort of students across our MSc programmes. In particular, we would like to congratulate our course prize w...
www.oncology.ox.ac.uk
October 20, 2025 at 3:01 PM
We would like to congratulate our MSc course prize winners, who each achieved the highest mark in their cohort for 2024-25.
Many congratulations to Maria, Jack, Carla & Yael on this outstanding achievement. We are confident they have impressive futures ahead as leaders in the field of oncology.
Many congratulations to Maria, Jack, Carla & Yael on this outstanding achievement. We are confident they have impressive futures ahead as leaders in the field of oncology.
For Senior Research Technician Erin Jarvis, the flexibility of the MSc in Precision Cancer Medicine offered the perfect opportunity to enhance her knowledge and skills, while continuing her work in the lab.
Erin shares her experience of the course & how it helped her prepare to pursue a PhD 👇
Erin shares her experience of the course & how it helped her prepare to pursue a PhD 👇
From MSc to PhD: Erin’s Journey in Precision Cancer Medicine
For Senior Research Technician Erin Jarvis, the flexibility of the MSc in Precision Cancer Medicine course offered the perfect opportunity to enhance her knowledge and skills, while continuing her wor...
www.oncology.ox.ac.uk
October 13, 2025 at 4:39 PM
For Senior Research Technician Erin Jarvis, the flexibility of the MSc in Precision Cancer Medicine offered the perfect opportunity to enhance her knowledge and skills, while continuing her work in the lab.
Erin shares her experience of the course & how it helped her prepare to pursue a PhD 👇
Erin shares her experience of the course & how it helped her prepare to pursue a PhD 👇
Reposted by University of Oxford Department of Oncology
Excited to share I’ve recently started as a group leader at the University of Oxford @oncology.ox.ac.uk, @ox.ac.uk
Feeling grateful for the people who’ve helped me get here, and looking forward to growing a lab that asks important questions (and hopefully finds some answers).
#NewPI #CancerResearch
Feeling grateful for the people who’ve helped me get here, and looking forward to growing a lab that asks important questions (and hopefully finds some answers).
#NewPI #CancerResearch
October 12, 2025 at 7:21 PM
Excited to share I’ve recently started as a group leader at the University of Oxford @oncology.ox.ac.uk, @ox.ac.uk
Feeling grateful for the people who’ve helped me get here, and looking forward to growing a lab that asks important questions (and hopefully finds some answers).
#NewPI #CancerResearch
Feeling grateful for the people who’ve helped me get here, and looking forward to growing a lab that asks important questions (and hopefully finds some answers).
#NewPI #CancerResearch